What is the difference between branded and compounded semaglutide prices?
When people search for semaglutide price, they are usually navigating a landscape with two very different product categories that share an active ingredient but differ in regulatory status, manufacturing standards, and cost structure.
| Category | Monthly price | FDA status | Requires prescription? |
|---|---|---|---|
| Branded GLP-1 (e.g., Ozempic/Wegovy) | $1,000+ list price | FDA-approved | Yes |
| Compounded semaglutide (licensed 503A pharmacy) | $99–$349/mo | Not FDA-approved | Yes |
Compounded semaglutide is legally prepared by licensed 503A pharmacies during periods when branded products are on the FDA shortage list. Cost is typically far lower, generally in the range of $99 to $349 per month depending on dose and platform.
What drives the semaglutide price difference?
Understanding why the prices diverge this sharply helps you evaluate what you are actually comparing.
Branded drug costs
The list price of branded semaglutide reflects the originator manufacturer’s decades of clinical development investment, patent protection, and the infrastructure to manufacture and distribute at scale with FDA oversight. It also reflects the pricing power that comes with patent protection and limited competition. Even with manufacturer discount programs, out-of-pocket costs for uninsured patients are often prohibitive.
Compounded semaglutide costs
A licensed 503A compounding pharmacy does not carry the originator’s development overhead. It purchases pharmaceutical-grade semaglutide as a bulk drug substance, prepares it to a clinician’s order, and dispenses it directly. The savings are real. The trade-off is that the compounded product is not FDA-approved and is not subject to the same pre-market approval requirements as branded drugs.
The key variable is pharmacy quality. A 503A pharmacy operating under rigorous quality controls, with USP-compliant sterile compounding practices, licensed pharmacists, and no hidden overseas supply chain, produces a meaningfully different product than a gray-market peptide vendor with none of those standards. The same molecule at two different facilities is not the same risk profile.
What does the monthly semaglutide price actually include?
When evaluating a quoted semaglutide price per month, it helps to understand what the total program cost typically breaks into.
- Clinician consultation: A licensed clinician must review your health history and prescribe any compounded medication. Some platforms bundle the consultation fee into the monthly price; others charge separately. A platform that skips this step is not operating legally.
- The compounded medication itself: This is the semaglutide dose, typically expressed in milligrams per weekly injection. Starting doses for weight management are lower than maintenance doses, so cost often increases as a program progresses and dose escalates.
- Supplies: Syringes, alcohol swabs, and sharps disposal containers. These may or may not be included.
- Ongoing check-ins: Quality programs include clinician follow-up to monitor progress, assess side effects, and adjust the protocol. This is not optional for safe use.
A monthly semaglutide price that looks remarkably low often signals that one or more of these components has been cut, frequently the clinician oversight.
What should you ask before starting a compounded semaglutide program?
Not all compounded semaglutide programs are equivalent. Before committing, the following questions are worth asking directly.
- Where is the pharmacy located, and is it 503A-licensed? A legitimate US-licensed 503A compounding pharmacy is the standard you want. No hidden overseas supply chain.
- Who is the prescribing clinician? There should be a licensed physician, nurse practitioner, or physician assistant reviewing your intake and issuing the prescription.
- What does the monthly price actually include? Get a line-item breakdown of medication, supplies, and consultation before committing.
- How are side effects and dose changes handled? You should have a direct channel to the clinical team, not just a chatbot.
How does the shortage affect the regulatory outlook?
Compounded semaglutide is legally available in the US under the shortage exemption. The FDA has signaled ongoing evaluation of the shortage status, and compounding rules could shift if the shortage is formally resolved. The current regulatory framework permits 503A pharmacies to compound semaglutide because branded products are not reliably accessible to all patients at all dose strengths.
If you are evaluating a program that involves compounded semaglutide, starting soon and ensuring you are working with a reputable clinical team and licensed pharmacy is more straightforward than waiting to see how the regulatory picture evolves. A clinician can advise you on the current access landscape at the time of your consultation.
Frequently asked questions about semaglutide price
How much does compounded semaglutide cost per month?
Compounded semaglutide from a licensed 503A pharmacy typically ranges from roughly $99 to $349 per month depending on the dose, the prescribing platform, and whether a clinician consultation fee is bundled. This is substantially lower than the list price of branded GLP-1 medications, which can exceed $1,000 per month before insurance.
Is compounded semaglutide the same as Ozempic or Wegovy?
Compounded semaglutide contains the same active molecule — semaglutide — but it is not the same product as Ozempic or Wegovy. Branded products are FDA-approved drugs manufactured to specific standards. Compounded semaglutide is prepared by a licensed 503A compounding pharmacy to a clinician's prescription. It is not FDA-approved. Claiming equivalence with a branded drug is inaccurate and not something a responsible provider should do.
Why is compounded semaglutide cheaper than the branded version?
Branded semaglutide carries the cost of the original manufacturer's clinical development, patent protection, and distribution infrastructure. Compounded semaglutide is prepared by a 503A pharmacy under a prescriber's order and does not carry those same overhead costs. The trade-off is that it is not FDA-approved and quality depends heavily on the pharmacy's standards and oversight.
Will my insurance cover compounded semaglutide?
Almost certainly not. Insurance coverage is generally limited to FDA-approved drugs at approved indications. Compounded medications are typically not reimbursable. Some HSA and FSA accounts may cover compounded prescriptions with a valid prescription — check your plan documents.
What is the semaglutide shortage, and does it affect compounding?
The FDA formally declared a shortage of branded semaglutide products. During an active shortage, 503A pharmacies are generally permitted to compound products containing the same active ingredient. If and when the shortage is formally resolved, the compounding exemption may change. The regulatory landscape around compounded GLP-1 medications is evolving; a licensed clinician can advise on current access.